InvestorsHub Logo
Followers 138
Posts 22888
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 09/18/2014 8:40:53 PM

Thursday, September 18, 2014 8:40:53 PM

Post# of 2206
Benitec's competition for hepatitis C treatment

"...The dropout rate for patients on Gilead Sciences' hepatitis C treatment Sovaldi is quadruple what was seen during clinical trials, data showed Wednesday...."

http://news.investors.com/091714-717783-gilead-disappointments-causing-shares-to-fall.htm?ven=yahoocp&src=aurlled&ven=yahoo

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News